Natural Product: NPC124155

Natural Product IDNPC124155
Common Name
?
The InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
4'-O-Glucosylaciculatin
IUPAC Name 8-[(2R,4S,5S,6R)-4,5-dihydroxy-6-methyloxan-2-yl]-5-hydroxy-7-methoxy-2-[4-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyphenyl]chromen-4-one
Synonyms 4'-O-Glucosylaciculatin
Synthetic Gene Cluster n.a.
ChEMBL Identifier CHEMBL2011653
PubChem CID 57332648
Chemical Classification
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000261] Phenylpropanoids and polyketides
      • [CHEMONTID:0000334] Flavonoids
        • [CHEMONTID:0001111] Flavonoid glycosides
          • [CHEMONTID:0001583] Flavonoid O-glycosides

The Chemical Classification was calculated by Classyfire, a software for chemical taxonomy calculation. Reference: DOI:10.1186/s13321-016-0174-y.

  Chemical Representations

Standard InCHIKey ZULIRTBISMVOJB-YZWJOIRQSA-N
Standard InCHI InChI=1S/C28H32O13/c1-11-23(33)16(32)9-19(38-11)22-18(37-2)8-15(31)21-14(30)7-17(40-27(21)22)12-3-5-13(6-4-12)39-28-26(36)25(35)24(34)20(10-29)41-28/h3-8,11,16,19-20,23-26,28-29,31-36H,9-10H2,1-2H3/t11-,16+,19-,20-,23-,24-,25+,26-,28-/m1/s1
SMILES C[C@@H]1[C@H]([C@H](C[C@H](c2c(cc(c3c(=O)cc(c4ccc(cc4)O[C@H]4[C@@H]([C@H]([C@@H]([C@@H](CO)O4)O)O)O)oc23)O)OC)O1)O)O

  Calculated Properties

Physi-Chem Properties

Molecular Weight:   576.18 Volume:   543.243
?
Van der Waals volume.
Dense:   1.061 LogP:   0.729
?
The logarithm of the n-octanol/water distribution coefficients.
logD7.4:   1.323
?
The logarithm of the n-octanol/water distribution coefficient at pH=7.4.
LogS:   -3.403
?
The logarithm of aqueous solubility value.
Rotatable Bonds:   6.0 Rigid Bonds:   30.0
TPSA:   208.74
?
Topological Polar Surface Area.
H-Bond Acceptor:   13.0
H-Bond Donor:   7.0 Rings:   5.0
Heavy Atoms:   13.0

MedChem Properties

QED Drug-Likeness Score:   0.205 GASA:   0.0
?
GASA represents the probability of being difficult to synthesize, ranging from 0 to 1.
Synthetic Accessibility Score:   4.682 Fsp3:   0.464
MCE-18:   115.098
?
MCE-18 stands for medicinal chemistry evolution.MCE-18≥45 is considered a suitable value.
Lipinski Rule-of-5:   Accepted
Pfizer Rule:   Rejected GSK Rule:   Accepted
Golden Triangle Rule:   Accepted BMS Rule:   0
Chelating Alert:   0 PAINS Alert:   0
Colloidal aggregators:   0.614 Fluc inhibitor:   0.151
?
The fluc inhibitor value is the probability of being fLuc inhibitors, within the range of 0 to 1.
Blue fluorescence:   0.929
?
The blue fluorescence value is the probability of being blue fluorescence, within the range of 0 to 1
Green fluorescence:   0.644
?
The green fluorescence value is the probability of being green fluorescence, within the range of 0 to 1
Reactive compounds:   0.082 Promiscuous compounds:   0.263

ADMET Properties (ADMETlab3.0)

ADMET: Absorption

Caco-2 Permeability:   -6.287 MDCK Permeability:   -5.301
Pgp-inhibitor:   0.0 Pgp-substrate:   0.752
PAMPA:   0.961
?
The experimental data for Peff was logarithmically transformed (logPeff). Molecules with log Peff values below 2.0 were classified as low-permeability (Category 0), while those with log Peff values exceeding 2.5 were classified as high-permeability (Category 1).
Human Intestinal Absorption (HIA):   0.062
20% Bioavailability (F20%):   0.055 30% Bioavailability (F30%):   0.959
50% Bioavailability (F50%):   0.996

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):   0.002 MRP1:   0.636
Plasma Protein Binding (PPB):   88.715% Volume Distribution (VD):   -0.047
Fu: 10.732%
?
The fraction unbound in plasms.
OATP1B1 inhibitor:   1.0
OATP1B3 inhibitor:   1.0 BCRP inhibitor:   0.11
BSEP inhibitor:   0.072

ADMET: Metabolism

CYP1A2-inhibitor:   0.0 CYP1A2-substrate:   0.0
CYP2C19-inhibitor:   0.0 CYP2C19-substrate:   0.0
CYP2C9-inhibitor:   0.0 CYP2C9-substrate:   0.0
CYP2D6-inhibitor:   0.0 CYP2D6-substrate:   0.0
CYP3A4-inhibitor:   0.0 CYP3A4-substrate:   0.286
CYP2B6-substrate:   0.0 CYP2C8-inhibitor:   0.966
HLM stability:   0.005
?
Human liver microsomal (HLM) stability. Category 0: stable+ (HLM > 30 min); Category 1: unstable- (HLM ≤ 30 min). The output value is the probability of human liver microsomal instability, where a value closer to 1 indicates a higher likelihood of instability.

ADMET: Excretion

Clearance (CL):  2.366 Half-life (T1/2):  4.515

ADMET: Toxicity

hERG Blockers:  0.026 hERG Blockers (10um):  0.09
Human Hepatotoxicity (H-HT):  0.838 Drug-induced Liver Injury (DILI):  0.993
AMES Toxicity:  0.98 Rat Oral Acute Toxicity:  0.129
Maximum Recommended Daily Dose:  0.184 Skin Sensitization:  0.996
Carcinogencity:  0.273 Eye Corrosion:  0.0
Eye Irritation:  0.079 Respiratory Toxicity:  0.081
Drug-induced Neurotoxicity:  0.008 Ototoxicity:  0.925
Hematotoxicity:  0.63 Drug-induced Nephrotoxicity:  0.853
Genotoxicity:  0.985 RPMI-8226 Immunitoxicity:  0.333
A549 Cytotoxicity:  0.784 Hek293 Cytotoxicity:  0.539
BCF:   0.496
?
Bioconcentration factors are used for considering secondary poisoning potential and assessing risks to human health via the food chain. The unit is -log10[(mg/L)/(1000*MW)].
IGC50:   3.297
?
48 hour Tetrahymena pyriformis IGC50. The unit of IGC50 is -log10[(mg/L)/(1000*MW)].
LC50DM:   4.908
?
48 hour Daphnia magna LC50. The unit of LC50DM is -log10[(mg/L)/(1000*MW)].
LC50FM:   3.993
?
96 hour fathead minnow LC50. The unit of LC50FM is -log10[(mg/L)/(1000*MW)].

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO32718 chrysopogon aciculatis Species n.a. n.a. n.a. n.a. n.a. PMID[22272829]

Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



  NP Quantity Composition/Concentration

Organism ID Organism Name Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



 Biological Activity

Molecular-level activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference

In vitro activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT83 Cell line MCF7 Homo sapiens IC50 > 100000.0 nM PMID[8021914]
NPT397 Cell line NCI-H460 Homo sapiens IC50 > 100000.0 nM DrugMatrix in vitro pharmacology data
NPT139 Cell line HT-29 Homo sapiens IC50 > 100000.0 nM PMID[16933875]
NPT404 Cell line CCRF-CEM Homo sapiens IC50 > 100000.0 nM PMID[8699183]

In vivo activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference





 Experimental ADME

Experiment Model Experiment Tissue ADME Type ADME Relation ADME Value ADME Unit Reference





 Experimental Toxicity

Quantitative toxicity

Experiment Model Experiment Organism Toxicity Type Toxicity Relation Toxicity Value Toxicity Unit Reference

Common Abbreviations:
LC: Lethal Concentration; LD: Lethal Dose; LT:Lethal Time; NOAEL: No-observed-adverse-effect Level; BMDL: Benchmark Dose Lower Confidence Limit; BMD: Benchmark Dose; BMC:Benchmark Concentration; LOAEL: Lowest Observed Adverse Effect Level; RfD:Reference Dose; RfC:Reference Concentration; MRL: Minimal Risk Level; MEG: Maximum Exposure Guideline; PAC: Protective Action Criteria

Categorical toxicity labels

Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption
Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP toxicity records from domain-specific databases. These databases include:
ToxValDB: a curated database that compiles quantitative toxicity values for chemicals from diverse public sources to support toxicological research and risk assessment.
TOXRIC: a comprehensive, free-to-access, online database providing toxicological/feature data. The toxicity labels are retrieved from this database. [PMID: 36400569]


  Chemically structural similarity

Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes approximately 50,000 NPs with experimentally-derived bioactivity available in NPASS)

Similarity is measured using the Tanimoto coefficient (Tc) , which compares the binary fingerprints of two molecules. Tc is calculated as the intersection divided by the union of '1' bits in the fingerprints, ranging from 0 to 1, with 1 indicating highest similarity.

●  The left chart: Distribution of similarity level between NPC124155 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.5 or Top200).

Similarity Score Similarity Level Natural Product ID
0.7059 Intermediate Similarity NPC607327
0.6292 Remote Similarity NPC95090
0.6292 Remote Similarity NPC27408
0.6044 Remote Similarity NPC186807
0.604 Remote Similarity NPC256760
0.6 Remote Similarity NPC58053
0.6 Remote Similarity NPC150767
0.5934 Remote Similarity NPC111341
0.5824 Remote Similarity NPC143851
0.58 Remote Similarity NPC606547
0.5789 Remote Similarity NPC607707
0.5684 Remote Similarity NPC22832
0.5684 Remote Similarity NPC243930
0.5556 Remote Similarity NPC603300
0.5545 Remote Similarity NPC106700
0.5545 Remote Similarity NPC131745
0.5484 Remote Similarity NPC39360
0.5484 Remote Similarity NPC29763
0.5484 Remote Similarity NPC210003
0.5417 Remote Similarity NPC609451
0.5368 Remote Similarity NPC105025
0.5333 Remote Similarity NPC5319
0.5319 Remote Similarity NPC261866
0.5306 Remote Similarity NPC88023
0.5306 Remote Similarity NPC311830
0.5306 Remote Similarity NPC309025
0.5263 Remote Similarity NPC189142
0.5263 Remote Similarity NPC77660
0.5208 Remote Similarity NPC181712
0.5204 Remote Similarity NPC605067
0.5158 Remote Similarity NPC289667
0.5155 Remote Similarity NPC201292
0.5152 Remote Similarity NPC220169
0.514 Remote Similarity NPC475382
0.5104 Remote Similarity NPC93337
0.5096 Remote Similarity NPC606373
0.5088 Remote Similarity NPC132111
0.5054 Remote Similarity NPC56232
0.5054 Remote Similarity NPC150123
0.5054 Remote Similarity NPC608009
0.5051 Remote Similarity NPC148710
0.5051 Remote Similarity NPC80188
0.5051 Remote Similarity NPC486578
0.5051 Remote Similarity NPC601144
0.505 Remote Similarity NPC211594

Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC124155 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.5 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.5333 Remote Similarity NPD7804 Clinical (unspecified phase)

Bioactivity similarity

  Bioactivity similarity

Similar Natural Products in NPASS

Similarity level is defined by Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.
Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data